Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.
about
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainInfiltrative microgliosis: activation and long-distance migration of subependymal microglia following periventricular insultsInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersHIV Associated Neurocognitive DisordersMechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disordersConditional Tat protein brain expression in the GT-tg bigenic mouse induces cerebral fractional anisotropy abnormalities.Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs.Crosstalk between HDAC6 and Nox2-based NADPH oxidase mediates HIV-1 Tat-induced pro-inflammatory responses in astrocytes.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.Genetic variation and HIV-associated neurologic disease.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesMinocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDSMorphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDSCreatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.Novel mechanisms of central nervous system damage in HIV infection.Autophagy in dementias.Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.Intra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in ratsOpiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytesHuman immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.Ketone bodies protection against HIV-1 Tat-induced neurotoxicity.Adenosine receptor signaling in the brain immune system.Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityHIV-Tat regulates macrophage gene expression in the context of neuroAIDS.Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse.Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions.PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium.Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport
P2860
Q24619923-82825187-291F-4AC0-BAB4-5C1E768BE804Q24803889-4A54E79B-1AAE-4420-A3AD-7E4399E4F687Q26770397-AE962009-F48B-4905-81A6-A245C90C5B25Q26777952-EBEFB98E-4F04-46A7-8AE4-B1378796211AQ27023968-C4A02D81-CC70-45AC-AFC9-C22C14047EE9Q28082139-5661FD56-251A-422B-83F5-65D3DB49DFCFQ30885921-CD7BD24E-EA0C-472F-8590-3B5BA72E1C2FQ33648905-D2A7FDD3-E477-4C62-BFCB-6D713F71005EQ33676138-F4F278DA-EE5F-454C-8FED-B0E36FB3BE45Q33753132-788ED0C8-B3AB-4F74-A626-9E1E714E2689Q33808035-C65E6E12-94BF-41DE-A8A0-D2079E3EA3ABQ33819189-BC7C1531-B955-47A3-897C-64BE321F996FQ33839136-8F0C61A2-A039-47F3-9575-8C8B6018B9CDQ33865700-C897869F-14E0-4547-8871-0630554145A0Q33873798-198F7985-CB52-45D3-9303-F071B1E14F5CQ33893395-4262F596-DD60-44AD-A0E9-51CC20DB3610Q34356438-6D005C10-AEF7-435F-BD6C-DC87CBB64F9AQ34450960-7571A0B9-8590-471B-9712-ADC1B44CA06AQ34483568-F0AEF792-EC97-4E89-A634-7A7524ED7B10Q34998247-2CC9E03F-7AE8-40A4-8502-B924EF9C0BE9Q35000860-25940257-0CAB-4DDD-8289-53D2CC8E1EDBQ35009483-0B5524C1-E082-4116-A177-E91080414B27Q35150753-B4F0BE0C-1395-4C7C-BC34-122AF170BA3EQ35215063-8E8C3206-44F6-4137-9BAF-036BE622516DQ35317241-2B3C3AAC-F030-48E0-85EA-B32225E0EC64Q35557261-3904CF01-2BCD-4010-9F9C-50E29265B000Q35624697-3B6194BB-B915-48A5-978D-A6E0DA4A511FQ35749130-7918472E-F280-4CE9-931C-E2758249F0DBQ35757268-5E73964E-C1E1-4460-ADE0-97FE04DA42A0Q35763921-80EC94AA-2ABA-4C1E-A24B-EB514B1A175EQ35857699-3E18D3B1-AD27-4AD5-AAE2-3FE2FC6090A6Q36148402-D99657E8-F40B-47AC-A438-1D5250671780Q36166231-1E48840D-FD94-457A-9AA7-6EA23F5030E2Q36242243-C12EF8AD-6F8D-46C3-A0E1-0CE0788C247BQ36296748-6AFA82A4-78B7-4544-82A7-3D1B6345A637Q36412589-E65D3E96-ED70-45B2-821C-E93A3AE778A6Q36632791-51A3E555-05C6-48A8-9395-5E9BC360B3B3Q36728173-711F799C-8CF5-4719-9235-CFE375D1E75CQ37366558-A3BBB602-61F7-404E-930E-6967F7ABA183Q37501478-EEA5A427-5701-4513-B03D-10AF2AB70113
P2860
Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Molecular pathway involved in ...... viral regulatory protein, Tat.
@ast
Molecular pathway involved in ...... viral regulatory protein, Tat.
@en
type
label
Molecular pathway involved in ...... viral regulatory protein, Tat.
@ast
Molecular pathway involved in ...... viral regulatory protein, Tat.
@en
prefLabel
Molecular pathway involved in ...... viral regulatory protein, Tat.
@ast
Molecular pathway involved in ...... viral regulatory protein, Tat.
@en
P2093
P1476
Molecular pathway involved in ...... viral regulatory protein, Tat.
@en
P2093
Alexander G
Del Valle L
Rappaport J
P304
P577
1999-04-01T00:00:00Z